BRPI0605832A2 - glicosìdeos de antraciclina liofilizados estáveis - Google Patents

glicosìdeos de antraciclina liofilizados estáveis

Info

Publication number
BRPI0605832A2
BRPI0605832A2 BRPI0605832-9A BRPI0605832A BRPI0605832A2 BR PI0605832 A2 BRPI0605832 A2 BR PI0605832A2 BR PI0605832 A BRPI0605832 A BR PI0605832A BR PI0605832 A2 BRPI0605832 A2 BR PI0605832A2
Authority
BR
Brazil
Prior art keywords
dried
hydrochloride
anthracycline
stable
anthracycline glycoside
Prior art date
Application number
BRPI0605832-9A
Other languages
English (en)
Inventor
Roberto Arosio
Marco Villa
Simonetta Amati
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of BRPI0605832A2 publication Critical patent/BRPI0605832A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20—Carbocyclic rings
    • C07H15/24—Condensed ring systems having three or more rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

GLICOSìDEOS DE ANTRACICLINA LIOFILIZADOS ESTáVEIS. A presente invenção fornece sais glicosídeos de antraciclina liofilizados e sais glicosídeos de antraciclina liofilizados estáveis, especialmente o sal hidrocloreto. Além disso, a presente invenção proporciona métodos para estabilizar esses sais glicosídeos de antraciclina e métodos para produzir sais glicosídeos de antraciclina liofilizados estáveis corno, por exemplo, o composto antineoplástico hidrocíoret~o de idarubicina, ou os compostos hidrocloreto de doxorubicina e hidrocloreto de epirubicina.
BRPI0605832-9A 2005-05-11 2006-05-11 glicosìdeos de antraciclina liofilizados estáveis BRPI0605832A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68013905P 2005-05-11 2005-05-11
PCT/US2006/018434 WO2006122309A2 (en) 2005-05-11 2006-05-11 Stable lyophilized anthracycline glycosides

Publications (1)

Publication Number Publication Date
BRPI0605832A2 true BRPI0605832A2 (pt) 2009-05-26

Family

ID=37397341

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0605832-9A BRPI0605832A2 (pt) 2005-05-11 2006-05-11 glicosìdeos de antraciclina liofilizados estáveis

Country Status (9)

Country Link
US (1) US20070004653A1 (pt)
EP (1) EP1814525A2 (pt)
JP (1) JP2008513519A (pt)
KR (1) KR20070088447A (pt)
BR (1) BRPI0605832A2 (pt)
CA (1) CA2606390A1 (pt)
MX (1) MX2007000413A (pt)
TW (1) TW200718426A (pt)
WO (1) WO2006122309A2 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ563365A (en) * 2005-06-02 2011-02-25 Schering Corp Combination of HCV protease inhibitors with a surfactant
US8119602B2 (en) * 2005-06-02 2012-02-21 Schering Corporation Administration of HCV protease inhibitors in combination with food to improve bioavailability
WO2009118754A2 (en) * 2008-03-28 2009-10-01 Astron Research Limited A process for preparing a stable lyophilized composition
DE102011103751A1 (de) * 2011-05-31 2012-12-06 Heraeus Precious Metals Gmbh & Co. Kg Kristallisierung von Epirubicinhydrochlorid
CN102614118B (zh) * 2012-03-15 2014-04-30 北京协和药厂 注射用盐酸表柔比星制剂的制备方法及制剂
CN103087124B (zh) * 2012-11-21 2016-01-13 浙江海正药业股份有限公司 一种制备阿霉素的方法
US20150087681A1 (en) * 2013-09-25 2015-03-26 Pranav Patel Bendamustine HCL Stable Lyophilized Formulations
CN104861014B (zh) * 2015-06-03 2017-09-29 道中道（菏泽）制药有限公司 一种盐酸表阿霉素结晶的制备方法
CN110483301A (zh) * 2018-06-11 2019-11-22 上海睿升化工科技有限公司 一种2-氧代戊烷-1,5-二甲酸二乙酯的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4012284A (en) * 1962-11-16 1977-03-15 Societa' Farmaceutici Italia, S.p.A. Process of preparation of antibiotic F.I. 1762 derivatives
YU33730B (en) * 1967-04-18 1978-02-28 Farmaceutici Italia Process for preparing a novel antibiotic substance and salts thereof
GB8426672D0 (en) * 1984-10-22 1984-11-28 Erba Farmitalia Pharmaceutical compositions
GB8519452D0 (en) * 1985-08-02 1985-09-11 Erba Farmitalia Injectable solutions
BE1000540A5 (fr) * 1986-12-05 1989-01-24 Erba Carlo Spa Solutions injectables pretes a l'emploi contenant un agent antitumeur du type anthracycline-glucoside.
FI883338A (fi) * 1987-07-16 1989-01-17 Bristol Myers Co Vattenloesningar av doxorubicinhydroklorid.
JP2603480B2 (ja) * 1987-08-05 1997-04-23 住友製薬株式会社 安定化されたアンスラサイクリン系製剤
GB9200247D0 (en) * 1992-01-07 1992-02-26 Erba Carlo Spa Pharmaceutical compositions containing polymer derivative-bound anthracycline glycosides and a method for their preparation
GB9926843D0 (en) * 1999-11-12 2000-01-12 Pharmacia & Upjohn Spa Lipid complex of alkycyclines
JP4594736B2 (ja) * 2002-11-29 2010-12-08 大日本住友製薬株式会社 安定化されたアンスラサイクリン系化合物の凍結乾燥製剤
US7485707B2 (en) * 2003-07-02 2009-02-03 Solux Corporation Thermally stable crystalline epirubicin hydrochloride and method of making the same

Also Published As

Publication number Publication date
TW200718426A (en) 2007-05-16
WO2006122309A3 (en) 2007-06-28
US20070004653A1 (en) 2007-01-04
WO2006122309A2 (en) 2006-11-16
JP2008513519A (ja) 2008-05-01
KR20070088447A (ko) 2007-08-29
EP1814525A2 (en) 2007-08-08
MX2007000413A (es) 2007-06-15
WO2006122309B1 (en) 2007-09-07
CA2606390A1 (en) 2006-11-16

Similar Documents

Publication Publication Date Title
BRPI0605832A2 (pt) glicosìdeos de antraciclina liofilizados estáveis
DOP2006000268A (es) Agentes antibacterianos
BRPI0519316B8 (pt) composição aquosa herbicida, e, processo para a preparação de uma composição
DOP2011000199A (es) Compuestos heterociclocos y metodos de uso
BRPI0720105A2 (pt) Conjugados de aminoácido não padrões de anfetamina e processos para fabricação e uso dos mesmos
BRPI0607765A2 (pt) pirazolopirimidinas
CL2008000789A1 (es) Compuestos derivados de adenina; composicion farmaceutica que comprende a dichos compuestos, utiles para tratar enfermedades alergicas, virales o cancer, entre otras.
BR112012031616A2 (pt) forma cristalina do inibidor de benzilbenzeno sglt2
HN2006011218A (es) Composiciones de tigeciclina y métodos de preparación
CR8568A (es) Macrolidos y metodos para producir los mismos
CO6480930A2 (es) Composiciones y procedimientos para preparar composiciones inmunogénicas de conjugado de polisacárido capsular de serotipo 5 y 8 de staphylococcus aureus.
CY1112511T1 (el) Κρυσταλλικη στερεα βαση ρασαγιλινης (rasagiline)
CL2011000206A1 (es) Composicion biocida que comprende ciprodinil y fluazinam; metodo para controlar enfermedades, en plantas utiles o en material de propagacion, causadas por fitopatogenos (div. sol. n°2602-06).
ATE552736T1 (de) Süssstoffzusammensetzung mit verbessertem geschmack
BRPI0815752A2 (pt) Mimético de peptídeo tipo nap ou mimético de peptídeo tipo sal, composição farmacêutica, e, método para tratar ou prevenir doenças.
BRPI0820290A2 (pt) Processo para preparar um sal de dibenzoil-l-tartarato diastereomericamente puro de um composto, mono-dibenzoil-l-tartarato, e, uso de um dibenzoil-l-tartarato.
GT200600349A (es) Compuestos orgánicos
WO2007016455A3 (en) Compositions and methods using aminoglycosides to bind dna and rna
GT200600010A (es) Procedimientos para la preparacion de alcoholes aminoetoxibencilicos
ATE492286T1 (de) Poly-epitop peptid abgeleitet aus der thymidylat- synthase mit immunologischer und anti-tumor aktivität
BRPI0411691A (pt) l-lisina de aztreonam e seus métodos de preparação
ITSV20050040A1 (it) Dispositivo per la guida di aghi, in particolare aghi di biopsia o simili
WO2007030802A3 (en) Targeted contrast agents and methods for targeting contrast agents
BR112013028390A2 (pt) agentes moluscicidas e seus usos
IL187639A0 (en) Crystalline azithromycin l-malate monohydrate and pharmaceutical compositions containing the same

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 3A, 4A, 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2161 DE 05/06/2012.